Meihua Intl Medical Tech Files 6-K Report

Ticker: MHUAF · Form: 6-K · Filed: Sep 20, 2024 · CIK: 1835615

Meihua International Medical Technologies Co., Ltd. 6-K Filing Summary
FieldDetail
CompanyMeihua International Medical Technologies Co., Ltd. (MHUAF)
Form Type6-K
Filed DateSep 20, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, regulatory-filing

TL;DR

Meihua Intl Medical Tech filed a 6-K report on 9/20/24 for the period ending 6/30/24, confirming it's a foreign private issuer filing 20-F.

AI Summary

Meihua International Medical Technologies Co., Ltd. filed a Form 6-K on September 20, 2024, reporting for the period ending June 30, 2024. The filing is a report of a foreign private issuer and indicates the company files annual reports under Form 20-F. The company's principal executive office is located in Yangzhou, People's Republic of China.

Why It Matters

This filing provides an update on the company's reporting status as a foreign private issuer, which is relevant for investors tracking its regulatory compliance and financial disclosures.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial results or significant corporate actions that would typically increase risk.

Key Players & Entities

  • Meihua International Medical Technologies Co., Ltd. (company) — Registrant
  • 0001213900-24-080741 (filing_id) — Accession Number
  • 20240920 (date) — Filing Date
  • 20240630 (date) — Reporting Period End Date
  • 001-41291 (company_id) — Commission File Number
  • 88 Tongda Road, Touqiao Town Guangling District, Yangzhou, 225000 People's Republic of China (address) — Principal Executive Office

FAQ

What type of report is Meihua International Medical Technologies Co., Ltd. filing?

The company is filing a Form 6-K, which is a Report of Foreign Private Issuer.

What is the reporting period for this 6-K filing?

The Conformed Period of Report is June 30, 2024.

When was this Form 6-K filed with the SEC?

The filing date (Accession Number) is September 20, 2024.

Does Meihua International Medical Technologies Co., Ltd. file annual reports under Form 20-F or 40-F?

The company indicates it files annual reports under cover of Form 20-F.

Where is the principal executive office of Meihua International Medical Technologies Co., Ltd. located?

The principal executive office is located at 88 Tongda Road, Touqiao Town, Guangling District, Yangzhou, 225000, People's Republic of China.

Filing Stats: 441 words · 2 min read · ~1 pages · Grade level 12.2 · Accepted 2024-09-20 17:20:19

Filing Documents

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 99.3 Press Release Titled "Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results" 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Meihua International Medical Technologies Co., Ltd. Dated: September 20, 2024 By: /s/ Xin Wang Name: Xin Wang Title: Chief Executive Officer (Principal Executive Officer) 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.